{"hands_on_practices": [{"introduction": "Differentiating atypical parkinsonian syndromes from each other and from idiopathic Parkinson's disease is one of the most challenging tasks in clinical neurology. The diagnosis hinges not on a single test, but on the careful synthesis of the patient's history, specific 'red flag' signs on examination, response to therapy, and neuroimaging patterns. This first practice exercise [@problem_id:4449677] challenges you to act as the consulting neurologist, integrating a rich clinical vignette to arrive at the most probable diagnosis by systematically weighing evidence for and against each possibility.", "problem": "A $68$-year-old person presents with a $2$-year history of progressively worsening slowness of movement and stiffness. The onset was insidious and symmetrical, with predominantly axial rigidity and marked gait instability. Within the first $6$ months, the patient sustained multiple unexplained backward falls despite no significant peripheral neuropathy or cerebellar ataxia on examination. There is hypophonia, spastic-appearing dysarthria, and a mild, low-amplitude postural tremor without a classic resting tremor. Neuro-ophthalmologic examination reveals markedly slowed vertical saccades and impaired voluntary upgaze and downgaze, yet the vestibulo-ocular (oculocephalic) reflex is preserved. A standardized levodopa trial at $800$ mg/day over $8$ weeks yielded minimal clinical improvement. Autonomic testing demonstrates no orthostatic hypotension exceeding a systolic blood pressure drop of $10$ mmHg and no urinary retention requiring catheterization. Magnetic Resonance Imaging (MRI) shows disproportionate midbrain atrophy with relative pontine preservation, producing a so-called “hummingbird” appearance; there is no “hot-cross bun” sign in the pons, and no marked putaminal rim hyperintensity. There are no cortical sensory deficits, no limb apraxia, and no alien limb phenomena. There is no stepwise progression, and brain MRI lacks confluent subcortical ischemic changes.\n\nUsing core definitions and well-tested facts about parkinsonian syndromes, classify the most likely diagnosis and justify your choice based on defining features that differentiate the major atypical parkinsonian syndromes from idiopathic Parkinson’s Disease (PD). Choose the single best option.\n\nA. Progressive Supranuclear Palsy (PSP), Richardson syndrome phenotype\n\nB. Parkinson’s Disease (PD)\n\nC. Multiple System Atrophy–parkinsonian type (MSA-P)\n\nD. Corticobasal Degeneration (CBD)\n\nE. Vascular parkinsonism", "solution": "The problem statement describes a clinical case and asks for the most likely diagnosis from a list of parkinsonian syndromes. The first step is to validate the problem statement.\n\n### PROBLEM VALIDATION\n\n**Step 1: Extract Givens**\n- **Patient Demographics:** $68$-year-old person.\n- **History of Present Illness:** $2$-year history of progressively worsening slowness of movement and stiffness.\n- **Motor Symptoms:**\n    - Insidious and symmetrical onset.\n    - Predominantly axial rigidity.\n    - Marked gait instability.\n    - Multiple unexplained backward falls within the first $6$ months of onset.\n    - Mild, low-amplitude postural tremor; no classic resting tremor.\n- **Speech:** Hypophonia and spastic-appearing dysarthria.\n- **Neuro-ophthalmology:**\n    - Markedly slowed vertical saccades.\n    - Impaired voluntary upgaze and downgaze.\n    - Preserved vestibulo-ocular (oculocephalic) reflex. This constellation defines a vertical supranuclear gaze palsy.\n- **Pharmacological Response:** Minimal clinical improvement on a standardized levodopa trial ($800$ mg/day for $8$ weeks).\n- **Autonomic Function:**\n    - No significant orthostatic hypotension (systolic blood pressure drop < $10$ mmHg).\n    - No urinary retention requiring catheterization.\n- **Neuroimaging (MRI):**\n    - Disproportionate midbrain atrophy with relative pontine preservation (\"hummingbird\" sign).\n    - No \"hot-cross bun\" sign in the pons.\n    - No marked putaminal rim hyperintensity.\n- **Cortical Function:**\n    - No cortical sensory deficits.\n    - No limb apraxia.\n    - No alien limb phenomena.\n- **Disease Course and Etiology:**\n    - No stepwise progression.\n    - MRI lacks confluent subcortical ischemic changes.\n- **Other Negatives:** No significant peripheral neuropathy or cerebellar ataxia on examination.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is evaluated against the established criteria:\n- **Scientifically Grounded:** The problem presents a detailed and coherent clinical vignette that is entirely consistent with established neurological science. The signs, symptoms, and radiological findings (e.g., supranuclear gaze palsy, \"hummingbird\" sign, poor levodopa response) are classic elements used in the differential diagnosis of atypical parkinsonian syndromes. The topic is central to the field of neurology.\n- **Well-Posed:** The problem provides sufficient, specific, and consistent information to allow for a differential diagnosis and to arrive at a single most likely answer among the given options.\n- **Objective:** The description uses precise, objective clinical terminology and quantitative data (e.g., levodopa dose, blood pressure drop) without resorting to subjective or ambiguous language.\n\n**Step 3: Verdict and Action**\nThe problem statement is scientifically sound, well-posed, objective, and internally consistent. It is a valid problem. The analysis will proceed to a solution.\n\n### DERIVATION OF THE SOLUTION\n\nThe provided clinical information points toward a specific diagnosis by including features highly characteristic of one condition while actively excluding others. The core task is to synthesize these findings.\n\n1.  **Core Syndrome:** The patient presents with parkinsonism, characterized by bradykinesia (slowness of movement) and rigidity (stiffness). However, several features suggest an \"atypical\" parkinsonian syndrome rather than idiopathic Parkinson's Disease (PD).\n\n2.  **Red Flags for Atypical Parkinsonism:**\n    *   **Symmetrical onset:** PD is classically asymmetric at onset.\n    *   **Early, severe postural instability:** Multiple falls within the first year (here, $6$ months) is a classic red flag. In PD, significant gait impairment and falls typically occur much later in the disease course.\n    *   **Poor response to levodopa:** A trial of up to $800$ mg/day is substantial. Minimal response strongly suggests a non-dopaminergic, postsynaptic pathology, characteristic of atypical syndromes.\n    *   **Specific eye movement abnormality:** The presence of a vertical supranuclear gaze palsy is a key localizing sign not found in PD.\n\n3.  **Differentiating Among Atypical Syndromes:**\n    *   **Progressive Supranuclear Palsy (PSP):** The patient's presentation is a textbook example of PSP, specifically the classic Richardson syndrome (PSP-RS). The cardinal features present are:\n        *   Early-onset postural instability with frequent unexplained backward falls.\n        *   Vertical supranuclear gaze palsy (impaired voluntary vertical saccades with preserved oculocephalic reflex).\n        *   Symmetrical axial rigidity.\n        *   Spastic dysarthria and dysphagia (implied by spastic dysarthria).\n        *   Poor levodopa response.\n        *   The \"hummingbird sign\" (or \"penguin silhouette sign\") on midsagittal MRI, reflecting severe atrophy of the midbrain tegmentum while the pons is relatively preserved, is highly specific for PSP.\n\n    *   **Multiple System Atrophy (MSA):** This diagnosis is effectively excluded by the stated lack of significant autonomic failure. MSA is defined by parkinsonism (MSA-P) or cerebellar ataxia (MSA-C) combined with early and severe autonomic failure (orthostatic hypotension meeting specific criteria—a systolic drop of $\\ge 20$ mmHg or diastolic drop of $\\ge 10$ mmHg—or urinary incontinence/retention). The patient's systolic BP drop is explicitly given as less than $10$ mmHg, and there is no urinary retention. The absence of the \"hot-cross bun\" sign on MRI further argues against MSA.\n\n    *   **Corticobasal Degeneration (CBD):** This diagnosis is excluded by the absence of its core features. CBD is characterized by striking asymmetry and prominent cortical signs, such as limb apraxia (inability to perform learned movements), cortical sensory loss, and/or the alien limb phenomenon. The patient's symptoms are symmetrical and lack these specific cortical deficits.\n\n    *   **Vascular Parkinsonism:** This is ruled out by the progressive nature of the decline (not stepwise) and the absence of confluent subcortical ischemic changes on brain MRI.\n\n**Conclusion:** The combination of early falls, symmetric axial parkinsonism, vertical supranuclear gaze palsy, and the characteristic \"hummingbird\" sign on MRI, in the context of a poor levodopa response and no significant autonomic or cortical dysfunction, makes Progressive Supranuclear Palsy (PSP), Richardson syndrome phenotype, the most likely diagnosis.\n\n### OPTION-BY-OPTION ANALYSIS\n\n**A. Progressive Supranuclear Palsy (PSP), Richardson syndrome phenotype**\nThis option aligns perfectly with the clinical picture. The key diagnostic pillars for PSP-RS are all present: early postural instability with falls ($< 1$ year), vertical supranuclear gaze palsy, and a poor levodopa response. The supportive feature of the \"hummingbird\" sign on MRI provides strong confirmatory evidence.\n**Verdict: Correct**\n\n**B. Parkinson’s Disease (PD)**\nThis diagnosis is inconsistent with the evidence. PD is typically characterized by asymmetric onset, a good initial response to levodopa, and the late development of postural instability. The presence of a vertical supranuclear gaze palsy is an exclusion criterion for a diagnosis of idiopathic PD.\n**Verdict: Incorrect**\n\n**C. Multiple System Atrophy–parkinsonian type (MSA-P)**\nThis diagnosis is contradicted by the explicit absence of significant autonomic failure. A defining criterion for MSA is severe autonomic dysfunction, which this patient does not have. The specific MRI and neuro-ophthalmologic findings (hummingbird sign, vertical supranuclear gaze palsy) point away from MSA and toward PSP.\n**Verdict: Incorrect**\n\n**D. Corticobasal Degeneration (CBD)**\nThis diagnosis is contradicted by the symmetrical nature of the parkinsonism and the absence of the characteristic cortical signs of CBD, such as apraxia, cortical sensory deficits, or alien limb phenomenon.\n**Verdict: Incorrect**\n\n**E. Vascular parkinsonism**\nThis diagnosis is excluded by the clinical course (progressive, not stepwise) and the MRI findings (lack of significant vascular changes). While gait dysfunction can be prominent, the other features in the vignette are not characteristic of vascular parkinsonism.\n**Verdict: Incorrect**", "answer": "$$\\boxed{A}$$", "id": "4449677"}, {"introduction": "While parkinsonism is a shared feature, the presence of early and severe autonomic failure is a key finding that points specifically toward Multiple System Atrophy (MSA). This hands-on practice [@problem_id:4449620] moves beyond recognizing symptoms to quantifying the underlying pathophysiology of neurogenic orthostatic hypotension (nOH). You will apply the precise clinical criteria for a significant blood pressure drop and, crucially, interpret the associated heart rate response to distinguish true autonomic failure from other causes of orthostasis.", "problem": "A $58$-year-old individual with rapidly progressive akinetic–rigid parkinsonism, early urinary and erectile dysfunction, and cerebellar ataxia is evaluated for possible Multiple System Atrophy (MSA). The differential diagnosis includes Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD). The patient reports lightheadedness after standing from supine. You perform standardized bedside measurements of blood pressure (BP) in millimeters of mercury (mmHg) and heart rate (HR) in beats per minute (bpm) after at least $5$ minutes supine rest, then at fixed intervals after active standing. Your task is to determine, using first principles of baroreflex physiology and accepted clinical definitions, which measurement pattern is most consistent with neurogenic orthostatic hypotension, defined by a sustained fall in BP within $3$ minutes of standing coupled with a blunted HR response.\n\nSelect all options that demonstrate a sustained drop of at least $20$ mmHg systolic or $10$ mmHg diastolic within $3$ minutes of standing with blunted HR increment, as would be expected in neurogenic orthostatic hypotension in MSA.\n\nA. Supine: BP $150/85$ mmHg, HR $62$ bpm; $1$ minute standing: BP $130/78$ mmHg, HR $64$ bpm; $3$ minutes standing: BP $128/76$ mmHg, HR $65$ bpm.\n\nB. Supine: BP $142/80$ mmHg, HR $70$ bpm; $1$ minute standing: BP $120/70$ mmHg, HR $92$ bpm; $3$ minutes standing: BP $118/68$ mmHg, HR $96$ bpm.\n\nC. Supine: BP $150/85$ mmHg, HR $64$ bpm; $1$ minute standing: BP $140/84$ mmHg, HR $80$ bpm; $3$ minutes standing: BP $138/82$ mmHg, HR $82$ bpm; $5$ minutes standing: BP $128/74$ mmHg, HR $84$ bpm.\n\nD. Supine: BP $135/78$ mmHg, HR $68$ bpm; $1$ minute standing: BP $118/70$ mmHg, HR $69$ bpm; $3$ minutes standing: BP $116/68$ mmHg, HR $70$ bpm.\n\nE. Supine: BP $155/95$ mmHg, HR $58$ bpm; $1$ minute standing: BP $120/75$ mmHg, HR $88$ bpm; $3$ minutes standing: BP $118/74$ mmHg, HR $86$ bpm.\n\nChoose all that apply.", "solution": "**Step-by-step Execution Plan:**\n\n**Part 1: Problem Validation**\n\n*   **Step 1: Extract Givens:**\n    *   Patient: $58$-year-old.\n    *   Symptoms: Rapidly progressive akinetic–rigid parkinsonism, early urinary and erectile dysfunction, cerebellar ataxia.\n    *   Clinical suspicion: Multiple System Atrophy (MSA).\n    *   Differential diagnoses: Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD).\n    *   Symptom reported by patient: Lightheadedness after standing from supine.\n    *   Procedure: Standardized bedside measurements of BP (mmHg) and HR (bpm) after at least $5$ minutes supine rest, then at fixed intervals after active standing.\n    *   Question: Determine which measurement pattern is most consistent with neurogenic orthostatic hypotension (nOH).\n    *   Definition of nOH provided:\n        *   Sustained fall in BP within $3$ minutes of standing.\n        *   BP fall criteria: at least $20$ mmHg systolic OR at least $10$ mmHg diastolic.\n        *   Associated finding: Blunted HR response.\n    *   Task: Select all options that demonstrate these criteria, as expected in nOH in MSA.\n\n*   **Step 2: Validate Using Extracted Givens:**\n    *   **Scientifically Grounded:** The problem describes a classic clinical scenario for MSA. The symptoms (parkinsonism, autonomic dysfunction, cerebellar ataxia) are the hallmark features of MSA. The investigation for orthostatic hypotension is a standard part of the workup. The definitions provided for orthostatic hypotension (sustained drop of at least $20$ mmHg systolic or $10$ mmHg diastolic within $3$ minutes) are the consensus criteria. The concept of a blunted heart rate response in nOH is a key pathophysiological principle, reflecting failure of the cardiovagal and sympathetic arms of the baroreflex. The problem is firmly grounded in established neurology and cardiovascular physiology.\n    *   **Well-Posed:** The problem is well-posed. It provides clear, quantitative criteria to evaluate the options. The task is to apply these criteria to the provided datasets (options A-E). A unique set of correct options can be determined.\n    *   **Objective:** The language is objective and clinical. The criteria are quantitative and not subject to interpretation.\n    *   **Check for flaws:**\n        1.  **Scientific/Factual Unsoundness:** No. The premises are sound.\n        2.  **Non-Formalizable/Irrelevant:** No. The problem is directly relevant to the topic of atypical parkinsonian syndromes and can be formalized using the given quantitative definitions.\n        3.  **Incomplete/Contradictory Setup:** The definition of a \"blunted HR response\" isn't given a strict numerical cut-off in the problem statement itself. However, in clinical practice and the literature, it's generally understood. The problem asks me to use \"first principles of baroreflex physiology\". In a normal baroreflex response to a BP drop, HR should increase significantly to compensate. A \"blunted\" response means the HR increase is absent or minimal. A common quantitative heuristic is that the ratio of HR increase (in bpm) to the systolic BP drop (in mmHg), i.e., $\\Delta HR / \\Delta SBP$, is less than $0.5$ bpm/mmHg. I can use this principle. This is a standard and justifiable interpretation based on \"first principles of baroreflex physiology\". The problem structure is designed to make this distinction possible.\n        4.  **Unrealistic/Infeasible:** No. The values for BP and HR are realistic clinical measurements.\n        5.  **Ill-Posed/Poorly Structured:** No. As discussed, while \"blunted HR\" is not strictly defined, its meaning within the context of autonomic failure is clear and allows for a logical solution. The question asks to identify patterns consistent with the definition, which is a standard task in clinical reasoning.\n        6.  **Pseudo-Profound/Trivial:** No. It's a straightforward application of clinical definitions, a standard problem type in medical education.\n        7.  **Outside Scientific Verifiability:** No. The principles are verifiable.\n\n*   **Step 3: Verdict and Action:** The problem is **valid**. I will proceed with the detailed solution.\n\nThe problem asks to identify measurement patterns consistent with neurogenic orthostatic hypotension (nOH) based on provided definitions and first principles of physiology. The clinical vignette describes a patient with symptoms highly suggestive of Multiple System Atrophy (MSA), a neurodegenerative disease characterized by autonomic failure.\n\nFirst, let us formalize the criteria for nOH as per the problem statement.\n1.  **Orthostatic Hypotension (OH):** A sustained fall in blood pressure (BP) within $3$ minutes of standing. The magnitude of the fall must satisfy:\n    -   A drop in systolic BP (SBP) of at least $20$ mmHg, i.e., $\\Delta SBP = SBP_{supine} - SBP_{standing} \\ge 20$ mmHg.\n    -   OR a drop in diastolic BP (DBP) of at least $10$ mmHg, i.e., $\\Delta DBP = DBP_{supine} - DBP_{standing} \\ge 10$ mmHg.\n\n2.  **Neurogenic Component:** The OH must be accompanied by a \"blunted HR increment\". From first principles of baroreflex physiology, a drop in BP is detected by baroreceptors, which normally triggers a compensatory increase in heart rate (HR) via the autonomic nervous system. In nOH, the autonomic nervous system is impaired, specifically the sympathetic efferent pathway, leading to an insufficient HR increase. A quantitative and clinically accepted heuristic for a blunted response is that the ratio of the HR increment to the SBP drop is small. We will use the common cutoff:\n    -   $\\frac{\\Delta HR}{\\Delta SBP} = \\frac{HR_{standing} - HR_{supine}}{SBP_{supine} - SBP_{standing}} < 0.5$ beats per minute / mmHg.\n\nWe will now analyze each option against these two criteria. The BP and HR changes will be calculated at the $3$-minute mark, unless otherwise specified, to assess the sustained drop.\n\n**Option A Evaluation**\n- Supine data: BP $150/85$ mmHg, HR $62$ bpm.\n- $3$ minutes standing data: BP $128/76$ mmHg, HR $65$ bpm.\n- **Criterion 1 (OH):**\n  - $\\Delta SBP = 150 - 128 = 22$ mmHg. Since $22 \\ge 20$, the systolic criterion is met.\n  - $\\Delta DBP = 85 - 76 = 9$ mmHg. The diastolic criterion is not met, but only one is required.\n  - The BP drop is sustained from $1$ minute to $3$ minutes. Thus, Criterion 1 is **met**.\n- **Criterion 2 (Blunted HR):**\n  - $\\Delta HR = 65 - 62 = 3$ bpm.\n  - The ratio is $\\frac{\\Delta HR}{\\Delta SBP} = \\frac{3}{22} \\approx 0.136$.\n  - Since $0.136 < 0.5$, the HR response is blunted. Criterion 2 is **met**.\n- **Verdict:** Option A demonstrates both a qualifying orthostatic BP drop and a blunted heart rate response. **Correct**.\n\n**Option B Evaluation**\n- Supine data: BP $142/80$ mmHg, HR $70$ bpm.\n- $3$ minutes standing data: BP $118/68$ mmHg, HR $96$ bpm.\n- **Criterion 1 (OH):**\n  - $\\Delta SBP = 142 - 118 = 24$ mmHg. Since $24 \\ge 20$, the systolic criterion is met.\n  - $\\Delta DBP = 80 - 68 = 12$ mmHg. Since $12 \\ge 10$, the diastolic criterion is also met.\n  - The BP drop is sustained. Thus, Criterion 1 is **met**.\n- **Criterion 2 (Blunted HR):**\n  - $\\Delta HR = 96 - 70 = 26$ bpm.\n  - The ratio is $\\frac{\\Delta HR}{\\Delta SBP} = \\frac{26}{24} \\approx 1.08$.\n  - Since $1.08 > 0.5$, the HR response is robust, not blunted. This pattern represents OH with an intact baroreflex (e.g., due to dehydration), not nOH. Criterion 2 is **not met**.\n- **Verdict:** Option B fails to show a blunted heart rate response. **Incorrect**.\n\n**Option C Evaluation**\n- Supine data: BP $150/85$ mmHg, HR $64$ bpm.\n- $3$ minutes standing data: BP $138/82$ mmHg, HR $82$ bpm.\n- The question specifies the drop must occur \"within $3$ minutes of standing\".\n- **Criterion 1 (OH):**\n  - At $3$ minutes: $\\Delta SBP = 150 - 138 = 12$ mmHg. This is less than $20$ mmHg.\n  - At $3$ minutes: $\\Delta DBP = 85 - 82 = 3$ mmHg. This is less than $10$ mmHg.\n  - Neither condition for OH is met within the specified $3$-minute window. The significant drop at $5$ minutes ($\\Delta SBP = 22$ mmHg) would be classified as delayed orthostatic hypotension, which is outside the scope of the definition provided in the problem. Thus, Criterion 1 is **not met**.\n- **Criterion 2 (Blunted HR):**\n  - Since Criterion 1 is not met, the pattern is not consistent with the definition of OH, and therefore cannot be nOH. The analysis can stop here.\n- **Verdict:** Option C does not meet the definition of orthostatic hypotension within the required timeframe. **Incorrect**.\n\n**Option D Evaluation**\n- Supine data: BP $135/78$ mmHg, HR $68$ bpm.\n- $3$ minutes standing data: BP $116/68$ mmHg, HR $70$ bpm.\n- **Criterion 1 (OH):**\n  - $\\Delta SBP = 135 - 116 = 19$ mmHg. Since $19 < 20$, the systolic criterion is not met.\n  - $\\Delta DBP = 78 - 68 = 10$ mmHg. Since $10 \\ge 10$, the diastolic criterion is met.\n  - The BP drop is sustained. Thus, Criterion 1 is **met**.\n- **Criterion 2 (Blunted HR):**\n  - $\\Delta HR = 70 - 68 = 2$ bpm.\n  - We use the SBP drop for the ratio calculation, as it reflects the primary hemodynamic stress: $\\frac{\\Delta HR}{\\Delta SBP} = \\frac{2}{19} \\approx 0.105$.\n  - Since $0.105 < 0.5$, the HR response is blunted. Criterion 2 is **met**.\n- **Verdict:** Option D demonstrates both a qualifying orthostatic BP drop (by diastolic criteria) and a blunted heart rate response. **Correct**.\n\n**Option E Evaluation**\n- Supine data: BP $155/95$ mmHg, HR $58$ bpm.\n- $3$ minutes standing data: BP $118/74$ mmHg, HR $86$ bpm.\n- **Criterion 1 (OH):**\n  - $\\Delta SBP = 155 - 118 = 37$ mmHg. Since $37 \\ge 20$, the systolic criterion is met.\n  - $\\Delta DBP = 95 - 74 = 21$ mmHg. Since $21 \\ge 10$, the diastolic criterion is also met.\n  - The BP drop is sustained. Thus, Criterion 1 is **met**.\n- **Criterion 2 (Blunted HR):**\n  - $\\Delta HR = 86 - 58 = 28$ bpm.\n  - The ratio is $\\frac{\\Delta HR}{\\Delta SBP} = \\frac{28}{37} \\approx 0.757$.\n  - Since $0.757 > 0.5$, the HR response is robust, not blunted. This is inconsistent with nOH. Criterion 2 is **not met**.\n- **Verdict:** Option E fails to show a blunted heart rate response. **Incorrect**.", "answer": "$$\\boxed{AD}$$", "id": "4449620"}, {"introduction": "Modern neuroimaging provides more than just a qualitative picture of the brain; it offers quantitative data that can significantly aid in diagnosis. For Progressive Supranuclear Palsy (PSP), a characteristic pattern of regional atrophy can be captured in a single, powerful metric. This exercise [@problem_id:4449679] guides you through the logic of constructing the Magnetic Resonance Parkinsonism Index (MRPI) from first principles, demonstrating how ratios of specific brain measurements can create a robust biomarker to help distinguish PSP from other parkinsonian syndromes.", "problem": "Atypical parkinsonian syndromes such as Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), and Parkinson’s disease (PD) show distinct and reproducible structural changes on brain Magnetic Resonance Imaging (MRI). Morphometric indices that are dimensionless and constructed from ratios of areas and linear widths are robust to intersubject scaling and facilitate discrimination among these syndromes. In PSP, there is well-documented atrophy of the midbrain and thinning of the superior cerebellar peduncles, whereas the pons area and the middle cerebellar peduncle are relatively less affected compared to PD and MSA. Starting from these widely accepted imaging observations and the principle that ratios of homologous measures provide normalization, define a dimensionless composite MRI-based index that integrates the relative pons-to-midbrain size and the relative middle-to-superior cerebellar peduncle width, known as the Magnetic Resonance Parkinsonism Index (MRPI). Then, compute this index for the following patient whose measurements were obtained in the mid-sagittal plane for areas and in the orthogonal plane for peduncle widths:\n\n- Midbrain area $A_{mb} = 101.3\\ \\mathrm{mm}^{2}$\n- Pons area $A_{p} = 479.8\\ \\mathrm{mm}^{2}$\n- Superior cerebellar peduncle width $w_{scp} = 2.41\\ \\mathrm{mm}$\n- Middle cerebellar peduncle width $w_{mcp} = 7.22\\ \\mathrm{mm}$\n\nExpress your final answer as a dimensionless number rounded to four significant figures. Do not include units in your final boxed answer.", "solution": "The problem requires the definition and calculation of the Magnetic Resonance Parkinsonism Index (MRPI), a dimensionless composite index used to help differentiate atypical parkinsonian syndromes. The definition must be derived from the provided principles of relative morphometry.\n\nFirst, let us establish the definition of the MRPI based on the given information. The goal is to create a dimensionless index that is sensitive to the structural changes characteristic of Progressive Supranuclear Palsy (PSP). The problem states that in PSP, there is atrophy of the midbrain (area denoted by $A_{mb}$) and thinning of the superior cerebellar peduncles (width denoted by $w_{scp}$). Conversely, the pons (area $A_{p}$) and the middle cerebellar peduncles (width $w_{mcp}$) are relatively spared.\n\nAn index designed to be elevated in PSP should therefore place the measures of the relatively preserved structures in the numerator and the measures of the atrophied structures in the denominator. This construction ensures the index value increases as the pathological changes of PSP become more pronounced.\n\nThe problem specifies two components to be integrated:\n1.  The \"relative pons-to-midbrain size\". This is a ratio of two areas. To reflect the relative preservation of the pons and atrophy of the midbrain in PSP, this ratio is defined as the pons area divided by the midbrain area:\n    $$ \\text{Ratio}_1 = \\frac{A_{p}}{A_{mb}} $$\n    This ratio is dimensionless, as it is an area divided by an area ($[\\text{length}]^2 / [\\text{length}]^2$).\n\n2.  The \"relative middle-to-superior cerebellar peduncle width\". This is a ratio of two widths. To reflect the relative preservation of the middle cerebellar peduncle and atrophy of the superior cerebellar peduncle in PSP, this ratio is defined as the middle cerebellar peduncle width divided by the superior cerebellar peduncle width:\n    $$ \\text{Ratio}_2 = \\frac{w_{mcp}}{w_{scp}} $$\n    This ratio is also dimensionless, as it is a length divided by a length ($[\\text{length}] / [\\text{length}]$).\n\nThe problem asks to \"integrate\" these two dimensionless ratios to form a single composite index, the MRPI. The most direct method to combine two independent ratios that both indicate the same underlying pathology is to multiply them. This enhances the discriminatory power of the resulting index. Therefore, the MRPI is defined as the product of these two ratios:\n$$ \\text{MRPI} = \\text{Ratio}_1 \\times \\text{Ratio}_2 = \\left( \\frac{A_{p}}{A_{mb}} \\right) \\times \\left( \\frac{w_{mcp}}{w_{scp}} \\right) $$\n\nNow, we can compute the value of the MRPI for the given patient data:\n- Midbrain area $A_{mb} = 101.3\\ \\mathrm{mm}^{2}$\n- Pons area $A_{p} = 479.8\\ \\mathrm{mm}^{2}$\n- Superior cerebellar peduncle width $w_{scp} = 2.41\\ \\mathrm{mm}$\n- Middle cerebellar peduncle width $w_{mcp} = 7.22\\ \\mathrm{mm}$\n\nSubstituting these values into the derived formula:\n$$ \\text{MRPI} = \\left( \\frac{479.8}{101.3} \\right) \\times \\left( \\frac{7.22}{2.41} \\right) $$\n\nFirst, we calculate the individual ratios:\n$$ \\frac{479.8}{101.3} \\approx 4.736426456 $$\n$$ \\frac{7.22}{2.41} \\approx 2.995850622 $$\n\nNext, we multiply these two results:\n$$ \\text{MRPI} \\approx 4.736426456 \\times 2.995850622 \\approx 14.1894980 $$\n\nThe problem requires the final answer to be rounded to four significant figures. The calculated value is $14.1894980...$. The fifth significant digit is $9$, which is greater than or equal to $5$, so we round up the fourth significant digit.\nThe resulting value is $14.19$.", "answer": "$$\\boxed{14.19}$$", "id": "4449679"}]}